JHLJa Hyvinvointialojen Liitto (Finnish: Public and Welfare Sectors Union; Finland)
JHLJournal of Human Lactation
JHLJess Heavy Lifter (aviation)
JHLJ Hvidtved Larsen A/S (sewer cleaning tankers manufacturer)
JHLJournal of the House of Lords (official publication; UK)
JHLJabr Ibn Hayan Laboratories (Iran)
References in periodicals archive ?
This is a turning point in JHL's history," said Racho Jordanov, co-founder and chief executive officer of JHL Biotech, "JHL was built on the foundation of world-class biologics capabilities.
This report provides comprehensive information on the current therapeutic developmental pipeline of JHL Biotech, Inc.
JHL was undertaking a six-month irrigation canal project that was supposed to be finished this month.
JHL, which specialises in bioengineering and innovative product development technologies, will use the proceeds from the funding round to develop its proprietary biosimilar monoclonal antibody pipeline and step up its filing of investigational new drug applications.
In March 2001, the Tokyo District Court invalidated the imposition of back taxes after determining the loans were all irrecoverable, but the high court overturned it, saying the taxation was appropriate as JHL had resources that made the loans recoverable.
Primary drivers of the pressure are expected to be continued high levels of credit-related losses at JHF's main operating company, JHL, and the potential need to provide support for JHL's statutory surplus in 2003.
GE Healthcare To Build KUBio Factory for JHL in China
The Norwegian software and outsourcing provider Visma ASA said on Monday (3 January) that its division Visma Software ASA had agreed to sell its direct sales subsidiary Spektrum Software AS to JHL Invest AS.
Biopharmaceutical startup JHL Biotech (TPEx:6540) disclosed on Friday the receipt of approval for the termination of trading of its shares from the Taipei Exchange (TPEx) on the Emerging Stock Market of TPEx.
JHL Biotech announced that its shareholders voted to voluntarily delist the companys ordinary shares from the Emerging Stock Market of the Taipei Exchange (TPex).
JHL Biotech Inc (Taipei:6540), a biopharmaceutical start-up, announced on Monday the appointment of Dr Rong Chen as chief medical officer, effective 1 January 2018.
JHL Biotech announced that Rong Chen has been appointed Chief Medical Officer effective January 1.